医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Ariul Fish LLC of Korea Launches Fish Product ‘Golden Tongue Sole’ Great for Health in Autumn

2019年11月18日 AM09:00
このエントリーをはてなブックマークに追加


 

GUNSAN, South Korea

Ariul Fish LLC, a Korean company specialized in fish, has launched fish product ‘Golden Tongue Sole’ made from Tongue Soles caught in a clean area of Gunsan.

Ariul’s carefully selected Korean tongue soles are semi-dried, rapidly cooled, and vacuum packed. Due to the recent air condition with heavy fine dust, the fishes are not dried with sea breeze but hygienic drying machines managed by the HACCP system. This drying method is specifically designed to preserve tongue soles’ freshness and flavor. The tongue sole is a perfect dish to regain the lost appetite caused by recent fine dust.

Tongue soles are sea fish that belongs to the family Cynoglossidae in order Pleuronectiformes. They inhabit mudflat and sand. The fishes are abundant in minerals and their flavor is soft and light without the fishy smell.

“People are suffering from the rise in prices, so we built various offers to lessen their burden,” Geum-ok Park, the president of Ariul Fish LLC said. “We hope the customers enjoy our fishes and be joyful.”

Ariul Fish’s semi-dried tongue soles gain attention from people when they were introduced in a famous TV show, Soomi’s Side Dishes, in which Kim Soo-mi demonstrated a super simple pan-fried tongue sole by grilling the fish on the pan lightly oiled with olive oil.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191117005005/en/

CONTACT

For Ariul Fish LLC

ADexpo Korea Co.,Ltd.

Jinju Lee, +82-2-6010-1102

adexpo@adexpo.co.kr

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続